Clinical Trials Directory

Trials / Completed

CompletedNCT02248727

Clinical Performance of Existing Wearers of Avaira Sphere Following a Refit With Clariti Elite Sphere

Clinical Performance of Existing Wearers of Avaira Sphere (Enfilcon A) Following a Refit With Clariti Elite Sphere (Somofilcon A) Lenses for 4 Weeks

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of this dispensing study is to evaluate the clinical performance of existing wearers of Avaira sphere lenses following a refit with Clariti Elite sphere over 4 weeks of daily wear.

Detailed description

This is a 30-subject, prospective dispensing study comparing the clinical performance of the subjects' habitual Avaira sphere lenses following a refit with Clariti Elite sphere lenses. Subject's habitual Avaira sphere lenses will be evaluated at the first visit and then re-fitted with a pair of Clariti Elite sphere lenses for 4 weeks of daily wear. After the dispensing visit, subjects will return for evaluations at 1 week, 2 weeks and 4 weeks.

Conditions

Interventions

TypeNameDescription
DEVICEsomofilcon Asomofilcon A lens

Timeline

Start date
2014-09-01
Primary completion
2014-10-01
Completion
2014-12-01
First posted
2014-09-25
Last updated
2020-07-28
Results posted
2016-03-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02248727. Inclusion in this directory is not an endorsement.